SEARCH

SEARCH BY CITATION

References

  • ARUNLAKSHANA, O. & SCHILD, H.O. (1959). Some quantitative uses of drug antagonists. Br. J. Pharmacol. Chemother., 14, 4858.
  • AUDIA, J.E., EVRARD, D.A., MURDOCH, G.R., DROSTE, J.J., NISSEN, J.S., SCHENCK, K.W., FLUDZINSKI, P., LUCAITES, V.L., NELSON, D.L. & COHEN, M.L. (1996). Potent, selective tetrahydro-β-carboline antagonists of the serotonin2B (5HT2B) contractile receptor in the rat stomach fundus. J. Med. Chem., 39, 27732780.
  • BAXTER, G.S. (1996). Novel discriminatory ligands for 5-HT2B receptors. Behav. Brain Res., 73, 149152.
  • BAXTER, G.S., KENNETT, G., BLANEY, F. & BLACKBURN, T. (1995). 5-HT2 receptor subtypes: a family re-united Trends Pharmacol. Sci., 16, 105110.
  • BAXTER, G.S., MURPHY, O.E. & BLACKBURN, T.P. (1994). Further characterization of 5-hydroxytryptamine receptors (putative 5-HT2B) in rat stomach fundus longitudinal muscle. Br. J. Pharmacol., 112, 323331.
  • BONHAUS, D.W., BACH, C., DESOUZA, A., SALAZAR, F.H.R., MATSUOKA, B.D., ZUPPAN, P., CHAN, H.W. & EGLEN, R.M. (1995). The pharmacology and distribution of human 5-hydroxytryptamine2B (5-HT2B) receptor gene products: comparison with 5-HT2A and 5-HT2C receptors. Br. J. Pharmacol., 115, 622628.
  • CUSHING, D.J., ZGOMBICK, J.M., NELSON, D.L. & COHEN, M.L. (1996). LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery. J. Pharmacol. Exp. Ther., 277, 15601566.
  • ELLIS, E.S., BYRNE, C., MURPHY, O.E. & BAXTER, G.S. (1994). 5-HT2B-like receptors mediate endothelium-dependent relaxation of rat jugular vein. Br. J. Pharmacol., 112, 477P.
  • ELLIS, E.S., BYRNE, C., MURPHY, O.E., TILFORD, N.S. & BAXTER, G.S. (1995). Mediation by 5-hydroxytryptamine2B receptors of endothelium-dependent relaxation in rat jugular vein. Br. J. Pharmacol., 114, 400404.
  • FURCHGOTT, R.F. (1972). The classification of adrenoceptors (adrenergic receptors). An evaluation from the standpoint of receptor theory. In Catecholamines, Handbook of Experimental Pharmacology, Vol. 33. eds. Blaschko, H. & Muscholl, E. pp. 283335. Berlin, Heidelberg, New York: Springer.
  • GLUSA, E. & RICHTER, M. (1993). Endothelium-dependent relaxation of porcine pulmonary arteries via 5-HT1C-like receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 347, 471477.
  • GLUSA, E. & ROOS, A. (1996). Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine. Br. J. Pharmacol., 119, 330334.
  • GRAYSON, K.L. & GUPTA, P. (1995). Preliminary characterization of an endothelial 5-HT receptor which mediates relaxation in a preparation of dog isolated vena cava. Br. J. Pharmacol., 116, 409P.
  • GUPTA, P. (1992). An endothelial 5-HT receptor that mediated relaxation in guinea-pig isolated jugular vein resembles the 5-HT1D subtype. Br. J. Pharmacol., 106, 703709.
  • HARTIG, P.R., HOYER, D., HUMPHREY, P.P.A. & MARTIN, G.R. (1996). Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes. Trends Pharmacol. Sci., 17, 103105.
  • HOYER, D. (1989). 5-Hydroxytryptamine receptors and effector coupling mechanism in peripheral tissues. In The Peripheral Actions of 5-Hydroxytryptamine. ed. Fozard, J.R. 7299. Oxford, New York, Tokyo: University Press.
  • HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157203.
  • KENNETT, G.A., AINSWORTH, K., TRAIL, B. & BLACKBURN, T.P. (1997). BW 723C86, a 5-HT2B receptor agonist, causes hyperphagia and reduced grooming in rats. Neuropharmacology, 36, 233239.
  • KOHEN, R., METCALF, M.A., KHAN, N., DRUCK, T., HUEBNER, K., LACHOWICZ, J.E., MELTZER, H.Y., SIBLEY, D.R., ROTH, B.L. & HAMBLIN, M.W. (1996). Cloning, characterization, and chromosomal location of a human 5-HT6 serotonin receptor. J. Neurochem., 66, 4657.
  • LEUNG, E., WALSH, L.K.M., PULIDO-RIOS, M.T. & EGLEN, R.M. (1996). Characterization of putative 5-ht7 receptors mediating direct relaxation in Cynomolgus monkey isolated jugular vein. Br. J. Pharmacol., 117, 926930.
  • MARTIN, G.R. (1994). Vascular receptors for 5-hydroxytryptamine: distribution, function and classification. Pharmacol. Ther., 62, 283324.
  • MARTIN, G.R., BROWNING, C. & GILES, H. (1993). Further characterization of an atypical 5-HT receptor mediating endothelium-dependent vasorelaxation. Br. J. Pharmacol., 110, 137P.
  • MARTIN, G.R. & WILSON, R.J. (1995). Operational characteristics of a 5-HT receptor mediating direct vascular relaxation: identity with 5-HT7 receptors Br. J. Pharmacol., 114, 383P.
  • MONSMA, F.J., SHEN, Y., WARD, R.P., HAMBLIN, M.W. & SIBLEY, D.R. (1993). Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol., 43, 320327.
  • MORECROFT, I. & MACLEAN, M.R. (1998). 5-Hydroxytryptamine receptors mediating vasoconstriction and vasodilation in perinatal and adult rabbit small pulmonary arteries. Br. J. Pharmacol., 125, 6978.
  • ROOS, A. & GLUSA, E. (1998). 5-HT-induced relaxation of porcine pulmonary arteries is mediated through endothelial 5-HT2B receptors. Naunyn-Schmiedeberg's Arch. Pharmacol., 357, R30.
  • ROTH, B.L., GRAIGO, S.C., CHOUDHARY, M.S., ULUER, A., MONSMA, F.J., SHEN, Y., MELTZER, H.J. & SIBLEY, D.R. (1994). Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J. Pharmacol. Exp. Ther., 268, 14031410.
  • SAXENA, P.R., DE VRIES, P., VILLALÓN, C.M. (1998). 5-HT1-like receptors: a time to bid goodbye. Trends Pharmacol. Sci., 19, 311316.
  • SAXENA, P.R. & VILLALÓN, C.M. (1990). Cardiovascular effects of serotonin agonists and antagonists. J. Cardiovasc. Pharmacol., 15, (Suppl. 7) S17S34.
  • SCHMUCK, K., ULMER, C., KALKMAN, H.O., PROBST, A. & LÜBBERT, H. (1996). Activation of meningeal 5-HT2B receptors: an early step in the generation of migraine headache Eur. J. Neurosci., 8, 959967.
  • SCHOEFFTER, P. & HOYER, D. (1990). 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype. J. Pharmacol. Exp. Ther., 252, 387394.
  • SHEN, Y., MONSMA, F.J., METCALF, M.A., JOSE, P.A., HAMBLIN, M.W. & SIBLEY, D.R. (1993). Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype. J. Biol. Chem., 268, 1820018204.
  • SUMNER, M.J. (1991). Characterization of the 5-HT receptor mediating endothelium-dependent relaxation in porcine vena cava. Br. J. Pharmacol., 102, 938942.
  • TERRÓN, J.A. (1996). The relaxant 5-HT receptor in the dog coronary artery smooth muscle: pharmacological resemblance to the cloned 5-ht7 receptor subtype. Br. J. Pharmacol., 118, 14211428.
  • TERRÓN, J.A. & FALCÓN-NERI, A. (1999). Pharmacological evidence for the 5-HT7 receptor mediating smooth muscle relaxation in canine cerebral arteries. Br. J. Pharmacol., 127, 609616.
  • THOMAS, D.R., GAGER, T.L., HOLLAND, V., BROWN, A.M. & WOOD, M.D. (1996). m-Chlorophenylpiperazine (mCPP) is an antagonist at the cloned human 5-HT2B receptor. NeuroReport, 7, 14571460.
  • ULMER, C., SCHMUCK, K., KALKMAN, H.O. & LÜBBERT, H. (1995). Expression of serotonin receptor mRNAs in blood vessels. FEBS Lett., 370, 215221.
  • WAINSCOTT, D.B., LUCAITES, V.L., KURSAR, J.D., BAEZ, M. & NELSON, D.L. (1996). Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences. J. Pharmacol. Exp. Ther., 276, 720727.